Compare · AZ vs TMO
AZ vs TMO
Side-by-side comparison of A2Z Cust2Mate Solutions Corp. (AZ) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AZ and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $179.14B, about 670.2x AZ ($267.3M).
- Over the past year, AZ is down 35.9% and TMO is up 16.3% - TMO leads by 52.2 points.
- TMO has been more active in the news (17 items in the past 4 weeks vs 1 for AZ).
- TMO has more recent analyst coverage (25 ratings vs 3 for AZ).
- Company
- A2Z Cust2Mate Solutions Corp.
- Thermo Fisher Scientific Inc
- Price
- $5.93-0.84%
- $482.27-2.41%
- Market cap
- $267.3M
- $179.14B
- 1M return
- -19.81%
- +6.57%
- 1Y return
- -35.89%
- +16.34%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 1
- 17
- Recent ratings
- 3
- 25
A2Z Cust2Mate Solutions Corp.
A2Z Smart Technologies Corp. provides services in the field of advanced engineering capabilities to the military/security markets and governmental agencies in Israel. The company produces unmanned remote-controlled vehicles and energy power packs; products for the civilian and retail markets; and fuel tank intelligent containment system, a capsule that can be placed in a fuel tank to prevent gas tank explosions. It also offers retail automation solutions for large grocery stores and supermarkets, as well as offers maintenance and calibration services to external and in-house complex electronic systems and products. A2Z Smart Technologies is headquartered in Vancouver, Canada.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest AZ
- Sidoti Events, LLC's May Micro-Cap Virtual Conference
- Amendment: SEC Form SCHEDULE 13G/A filed by A2Z Cust2Mate Solutions Corp.
- Amendment: SEC Form SCHEDULE 13G/A filed by A2Z Cust2Mate Solutions Corp.
- A2Z Provides Update to Financial Results for First Quarter 2026
- SEC Form EFFECT filed by A2Z Cust2Mate Solutions Corp.
- A2Z Announces Financial Results for First Quarter 2026
- A2Z Cust2Mate Secures Approval for $30 Million Non-Dilutive Financing to Scale Smart Cart Manufacturing & Deployment
- A2Z Cust2Mate Strengthens Retail Media Position as Advertisers Tap Smart Carts for In-Store Reach
- A2Z Cust2Mate Solutions to Host First Quarter 2026 Financial Results Conference Call on Friday, May 15, 2026
- A2Z Cust2Mate Expands into Home Goods Retail, Deploying 2,000 Smart Shopping Carts at HaStock
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)